​

Champions Oncology (CSBR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CSBR Stock Forecast

Champions Oncology (CSBR) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $12.00, with a high of $12.00 and a low of $12.00. This represents a 62.16% increase from the last price of $7.40.

$3 $4 $5 $6 $7 $8 $9 $10 $11 $12 High: $12 Avg: $12 Low: $12 Last Closed Price: $7.4

CSBR Stock Rating

Champions Oncology stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (71.43%), 2 Hold (28.57%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 2 5 Strong Sell Sell Hold Buy Strong Buy

CSBR Price Target Upside V Benchmarks

TypeNameUpside
StockChampions Oncology62.16%
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$12.00
Last Closing Price$7.40$7.40$7.40
Upside/Downside--62.16%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-1---1
May, 25-1---1
Apr, 25-1---1
Mar, 25-1---1
Feb, 25-1---1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 12, 2025Craig-Hallum$12.00$9.5525.65%62.16%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 12, 2024Craig-HallumBuyupgrade

Financial Forecast

EPS Forecast

Apr 21 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27
Apr 21Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27
Reported$0.03$0.04$-0.39$-0.54---
Avg Forecast$0.06$0.12$-0.29$-0.63$0.21$0.24-
High Forecast$0.06$0.12$-0.29$-0.63$0.21$0.24-
Low Forecast$0.06$0.12$-0.29$-0.63$0.21$0.24-
Surprise %-50.00%-66.67%34.48%-14.29%---

Revenue Forecast

$40M $46M $52M $58M $64M $70M Apr 21 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27
Apr 21Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27
Reported$41.04M$49.11M$53.87M----
Avg Forecast$40.53M$49.00M$53.64M$48.80M$56.10M$61.80M$69.86M
High Forecast$40.53M$49.00M$53.64M$48.80M$56.10M$61.80M$69.86M
Low Forecast$40.53M$49.00M$53.64M$48.80M$56.10M$61.80M$69.86M
Surprise %1.27%0.22%0.43%----

Net Income Forecast

$-10M $-7M $-4M $-1M $2M $5M Apr 21 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27
Apr 21Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27
Reported$362.00K$548.00K$-5.33M$-7.28M---
Avg Forecast$767.70K$1.63M$-3.93M$-8.53M$2.84M$3.25M-
High Forecast$767.70K$1.63M$-3.93M$-8.53M$2.84M$3.25M-
Low Forecast$767.70K$1.63M$-3.93M$-8.53M$2.84M$3.25M-
Surprise %-52.85%-66.29%35.79%-14.75%---

CSBR Forecast FAQ

Is Champions Oncology stock a buy?

Champions Oncology stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Champions Oncology is a favorable investment for most analysts.

What is Champions Oncology's price target?

Champions Oncology's price target, set by 7 Wall Street analysts, averages $12 over the next 12 months. The price target range spans from $12 at the low end to $12 at the high end, suggesting a potential 62.16% change from the previous closing price of $7.4.

How does Champions Oncology stock forecast compare to its benchmarks?

Champions Oncology's stock forecast shows a 62.16% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for Champions Oncology over the past three months?

  • June 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Champions Oncology’s EPS forecast?

Champions Oncology's average annual EPS forecast for its fiscal year ending in April 2025 is $0.21, marking a -138.89% decrease from the reported $-0.54 in 2024. Estimates for the following years are $0.24 in 2026, and $0 in 2027.

What is Champions Oncology’s revenue forecast?

Champions Oncology's average annual revenue forecast for its fiscal year ending in April 2025 is $56.1M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $61.8M, and $69.86M for 2027.

What is Champions Oncology’s net income forecast?

Champions Oncology's net income forecast for the fiscal year ending in April 2025 stands at $2.84M, representing a -139.10% decrease from the reported $-7.276M in 2024. Projections indicate $3.25M in 2026, and $0 in 2027.